Xu, J., et al. 79 TUMOR-IMMUNE SIGNATURES ASSOCIATED WITH RESPONSE OR RESISTANCE TO TISLELIZUMAB (ANTI-PD1) IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC). Journal for Immunotherapy of Cancer 2020(8)S3:A1-A959
Hou, M. M., et al. 77 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC). Journal for Immunotherapy of Cancer 2020(8)S3. Pre-print
Ye, D., et al. 78 T-Cell, MHC I, and tumor intrinsic gene signatures predict clinical benefit and resistance to tislelizumab monotherapy in pretreated PD-L1+ urothelial carcinoma. Journal for Immunotherapy of Cancer 2020(8)S3: A1-A959- pre-print
Baron, C. et al. Circulating miRNAs as a non-invasive Diagnostic Tool to Predict Implantation Failure. American Society for Reproductive Medicine. Abstract presented at the Virtual Congress 2020 OCT 17-21. VOL. 114; S3
Yamoah, K., et al. Comparative Transcriptomics of Prostate Tumor Show Enrichment of Biologically Distinct Pathways Among Men of African Origin. International Journal of Radiation Oncology, Biology, Physics. Oral Scientific Session 2020 NOV 1 (108)3;S48
Hahn, N., et al. Extraction-Free Comprehensive Transcriptome Sequencing of Carcinoma in Situ Is Highly Feasible and Insightful in Non-Muscle Invasive Bladder Cancer. Abstract presented at IBCN 2020 Virtual Meeting: 2020 OCT 17. UroToday Conference Highlights.
Tiemann, A., et al. Comparison of immunohistochemical and gene expression profiling based subtype identification of diffuse large B-cell lymphoma. Focus on extranodal lymphoma. Poster and Abstract 263 presentedDeutsche Gesellschaft Fur Hamatologie Und Medizinische Onkologie. at Virtual Annual Meeting 2020 OCT 9 - 11.
Menter, T., et al. Analysis of the microenvironment of follicular lymphoma by gene expression analysis: importance of the Th17 axis. Abstract presented at the 104th Annual Meeting of the German Society for Pathology 2020 Jun 4-6; Virtual Conference
Inaki, K., et al. Pan-cancer gene expression analysis of tissue microarray using EdgeSeq Oncology biomarker Panel and a cross-comparison with ERBB3 immunohistochemical analysis. Abstract presented at: American Association for Cancer Research (AACR) Virtual Annual Meeting 2020 June 22-24. Online Proceedings. Session PO.MCB09.01 Functional Genomics and Other Topics
Download pdf 1.1MB
View External Link
O'Rourke, D., et al. Comparison of HTG-edge targeted RNA sequencing platform with whole transcriptome RNA sequencing for clinical biomarker studies. Abstract presented at: American Association for Cancer Research (AACR) Virtual Annual Meeting 2020 June 22-24. Online Proceedings. Session PO.CL11.02 Predictive Biomarkers for Treatment Efficacy 1
Download pdf 249KB
View External Link
Moura, D. S., et al. Immune-checkpoint genes as predictive biomarkers of trabectedin in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) translational study. J Clin Oncol 38: 2020 (suppl; abstr 11546). DOI: 10.1200/JCO.2020.38.15_suppl.11546
Download jpg 6.0MB
View External Link
Ran, D., et al. Platform comparison of HTG edgeSeq and RNA-Seq for gene expression profiling of tumor tissue specimens. J Clin Oncol 38:2020 (suppl; abst 3566).
Download jpg 2.7MB
View External Link
Page last updated November 25, 2020